Literature DB >> 28217436

The first report of onychomycosis caused by Cryptococcus friedmannii (Naganishia friedmannii) a basidiomycetous yeast.

Masoome Ekhtiari1, Shirin Farahyar1, Mehraban Falahati1, Elham Razmjou1, Mahtab Ashrafi-Khozani1, Zeinab Ghasemi2, Ziba Abbasi-Nejat3.   

Abstract

Yeasts are common etiologic agents of onychomycosis. This study reported a case of onychomycosis due to Cryptococcus friedmannii (Naganishia friedmannii). This yeast was isolated of the right great toenail of 57-year-old man. Microscopic examination of nail scrapings showed budding cells with thin capsule. Sequence analyzes of the internal transcribed spacer regions was closely related to Cryptococcus friedmannii. The results of susceptibility testing showed the Cryptococcus friedmannii to be sensitive to fluconazole, itraconazole and amphotericin B.

Entities:  

Keywords:  Antifungal susceptibility; Basidiomycetous yeast; Cryptococcus friedmannii; Onychomycosis

Year:  2017        PMID: 28217436      PMCID: PMC5302186          DOI: 10.1016/j.mmcr.2017.01.002

Source DB:  PubMed          Journal:  Med Mycol Case Rep        ISSN: 2211-7539


Introduction

Onychomycosis is a common nail infection due to yeasts and filamentous fungi [1], [2]. The uncommon fungi such as Trichosporon mucoides [3] Aspergillus clavatus [4] and Cryptococcus spp. (basidiomycetous yeasts) [5] were reported as emerging pathogens of onychomycosis. The basidiomycetous yeasts are important in economic, agricultural and medical problems [6]. Cryptococcus neoformans (Cr. neoformans) was an important agent of cryptococcal infections in immunocompromised patients and Cr. gatti is the major pathogen in the genus as well [7], [8]. However the reports of infections due to non-neoformans have been increased [9]. The species of Cryptococcus genus have been identified from different environmental sources such as air, water, soil, wood, and pigeon excreta. Cr. friedmannii was reported as a new species of yeast from Antarctic in 1985 [10]. The other studies reported that Cr. friedmannii isolated from Beringian and Icelandic soils which were more vegetated. This kind of yeast was reported from soil of Tabriz in Iran as well [11], [12]. Cr. friedmannii and some of the yeast species were isolated from the Atacama Desert, with high daily temperature variations. Cr. friedmannii had ability to survive at moderate to cold temperatures [13]. Cr. friedmannii has not been reported as an agent of onychomycosis.

Case

A 57-year-old man was admitted to our department in October 2015 (at day 0) with distal subungual hyperkeratosis clinical type of onychomycosis on the first right toenail (Fig. 1). The patient did not have disease like diabetes, psoriasis, immunodeficiencies or any chronic disease. However, four months ago (at day – 4 months), the patient had a history of ungueal trauma and small traumatic lesion was emerged on toenail. Three direct microscopic examinations (at day 0) of nail scrapings, with 20% potassium hydroxide revealed single or budding yeast cells. Three nail specimens were cultured on sabourauds dextrose agar plates with chloramphenicol (at day 0), and incubated at 20–25 °C, which were produced creamy and smooth colonies after a few days (Fig. 2). The other fungi were not isolated. Microscopic examinations (at day 7) of the colonies with Chinese ink were shown single or budding cells with a thin capsule (Fig. 3). Also, lactophenol cotton blue wet mount slide of colonies showed budding cells (Fig. 4). For molecular identification, the yeast was cultured on yeast extract peptone dextrose agar and incubated at 20–25 °C.
Fig. 1

Distal subungual thickening and hyperkeratosis of patient.

Fig. 2

Creamy and smooth colonies of Cr. friedmannii on sabourauds dextrose agar plate with chloramphenicol.

Fig. 3

Budding cells with a thin capsule with Chinese ink wet mount (×400).

Fig. 4

Budding cells in lactophenol cotton blue wet mount slide of colonies (×400).

Distal subungual thickening and hyperkeratosis of patient. Creamy and smooth colonies of Cr. friedmannii on sabourauds dextrose agar plate with chloramphenicol. Budding cells with a thin capsule with Chinese ink wet mount (×400). Budding cells in lactophenol cotton blue wet mount slide of colonies (×400). Genomic DNA was extracted using Qiagen tissue kit (Germany) (at day 11). The ITS1-5.8S-ITS2 region was amplified with ITS1 (TCC GTA GGT GAA CCT GCG G) and ITS4 (TCC TCC GCT TAT TGA TAT GC) universal primers by the following profile: 98 °C (5 min), 40 cycles of 98 °C (30 s), annealing temperature 56 °C (30 s), and 72 °C (30 s), followed by a final extension of 72 °C (5 min). Amplification of the isolate with ITS1 and ITS4 primers yielded 500 bp fragment (at day 11). The PCR products were sequenced by Macrogen (Korea). Sequence analyzes was compared with the reference sequences of GenBank database using BLAST (basic local alignment search tool) (http://www.ncbi.nlm.nih.gov/BLAST). Sequence analyzes was 100% related to Cr. friedmannii (Naganishia friedmannii) with the accession number KM243311.1 (at day 23). The sequence of the ITS region was submitted to the GeneBank as the accession number KX268322 (Fig. 5).
Fig. 5

The sequence of the ITS region was submitted to the GeneBank as the accession number KX268322.

The sequence of the ITS region was submitted to the GeneBank as the accession number KX268322. The antifungal susceptibilities were conducted according to the Clinical and Laboratory Standard Institute method (document M27-S3). The susceptibility tests of Cr. friedmannii to fluconazole, Itraconazole and amphotericin B was determined at 72 h. The MICs results revealed this isolate was susceptible to these drugs with MIC values of 0.25, 0.125 and 0.25 μg/ml for fluconazole, itraconazole and amphotericin B, respectively (at day 30). The patient was treated with oral itraconazole at the dosage of 200 mg daily. Three months later, the symptoms of disease complete remission of the nail. Direct microscopic examinations of nail scrapings with 20% potassium hydroxide had not revealed single or budding yeast cells and culture of the nail sample was negative.

Discussion

The yeast Cr. friedmannii was first reported as a new species of basidiomycetous yeast of Antarctic in 1985 [10]. The incidence of infection due to non- Cr. neoformans has increased. This increased may reveal enhanced immunocompromised patients with impaired cell-mediated immunity, organ transplantation, diabetic patients, azole prophylaxis, and etc [9]. Some of non- Cr. neoformans species, such as Cr. laurentii, Cr. albidus, Cr. luteolus, Cr. uniguttulatus, Cr. curvatus and Cr. humicola were reported as opportunistic pathogens over the last few years [9], [14]. A case of Cr. laurentii keratitis was reported in diabetic patient with onychomycosis. Cultures of the nail and of the contact lens have shown Cr. laurentii and Fusarium solani [15]. Three species of Cryptococcus (Cr. albidus, Cr. uniguttulatus and Cr. laurentii) were isolated of onychomycosis in type 2 diabetes mellitus patients [5]. Also, Prothoteca spp was reported as the first causative agent of onychomycosis in Brazil which was the 3rd case in the world [16]. The distribution of pathogens of onychomycosis is not uniform. It is related to several factors such as geographical region and climatic conditions. Furthermore, onychomycosis is related to the host ones such as age, occupation, chronic diseases, nail care and lifestyle. Deformity and pain in nails are caused by the fungi in onychomycosis. Thus, affected individuals may experience difficulties while walking and writing. Therefore, accurate diagnosis of the agents is important for suitable therapeutic approach. This study reports Cr. friedmannii is the first case of onychomycosis in the world.

Conflict of interest

There are none.
  15 in total

1.  Cryptococcus friedmannii, a new species of yeast from the Antarctic.

Authors:  H S Vishniac
Journal:  Mycologia       Date:  1985 Jan-Feb       Impact factor: 2.696

2.  Biodiversity and systematics of basidiomycetous yeasts as determined by large-subunit rDNA D1/D2 domain sequence analysis.

Authors:  J W Fell; T Boekhout; A Fonseca; G Scorzetti; A Statzell-Tallman
Journal:  Int J Syst Evol Microbiol       Date:  2000-05       Impact factor: 2.747

3.  A unique case of Cryptococcus laurentii keratitis spread by a rigid gas permeable contact lens in a patient with onychomycosis.

Authors:  D C Ritterband; J A Seedor; M K Shah; S Waheed; I Schorr
Journal:  Cornea       Date:  1998-01       Impact factor: 2.651

Review 4.  Susceptibility profile of clinical isolates of non-Cryptococcus neoformans/non-Cryptococcus gattii Cryptococcus species and literature review.

Authors:  Leticia Bernal-Martinez; Alicia Gomez-Lopez; Maria V Castelli; Ana C Mesa-Arango; Oscar Zaragoza; Juan L Rodriguez-Tudela; Manuel Cuenca-Estrella
Journal:  Med Mycol       Date:  2010-02       Impact factor: 4.076

Review 5.  What makes Cryptococcus gattii a pathogen?

Authors:  Ewa Bielska; Robin C May
Journal:  FEMS Yeast Res       Date:  2015-11-26       Impact factor: 2.796

6.  Onychomycosis incidence in type 2 diabetes mellitus patients.

Authors:  Patricia Manzano-Gayosso; Francisca Hernández-Hernández; Luis Javier Méndez-Tovar; Yanni Palacios-Morales; Erika Córdova-Martínez; Elva Bazán-Mora; Rubén López-Martinez
Journal:  Mycopathologia       Date:  2008-03-29       Impact factor: 2.574

7.  Onychomycosis caused by Trichosporon mucoides.

Authors:  Gaetano Rizzitelli; Elena Guanziroli; Annalisa Moschin; Roberta Sangalli; Stefano Veraldi
Journal:  Int J Infect Dis       Date:  2015-11-19       Impact factor: 3.623

8.  A case of onychomycosis caused by Aspergillus candidus.

Authors:  Bahram Ahmadi; Seyed Jamal Hashemi; Farideh Zaini; Mohammad Reza Shidfar; Maryam Moazeni; Bita Mousavi; Fatemeh Noorbakhsh; Mohsen Gheramishoar; Leila Hossein Pour; Sassan Rezaie
Journal:  Med Mycol Case Rep       Date:  2012-07-03

9.  Descriptive study of onychomycosis in a hospital in São Paulo.

Authors:  Clarissa Santos de Carvalho Ribeiro; Clarisse Zaitz; Valéria Maria de Souza Framil; Thaíssa Santos de Carvalho Ottoboni; Melissa Santos de Carvalho Tonoli; Renata Pinto Ribeiro; Renata Pinheiro Ribeiro
Journal:  Braz J Microbiol       Date:  2015-06-01       Impact factor: 2.476

Review 10.  Non-neoformans cryptococcal infections: a systematic review.

Authors:  T Khawcharoenporn; A Apisarnthanarak; L M Mundy
Journal:  Infection       Date:  2007-04       Impact factor: 3.553

View more
  2 in total

1.  Molecular epidemiology and antifungal susceptibility profiles of clinical Cryptococcus neoformans/Cryptococcus gattii species complex.

Authors:  Zainab Bandalizadeh; Tahereh Shokohi; Hamid Badali; Mahdi Abastabar; Farhang Babamahmoudi; Lotfolah Davoodi; Masoud Mardani; Mostafa Javanian; Hamed Cheraghmakani; Ali Asghar Sepidgar; Parisa Badiee; Sadegh Khodavaisy; Setareh Agha Kuchak Afshari; Kazem Ahmadikia; Seyedmojtaba Seyedmousavi
Journal:  J Med Microbiol       Date:  2020-01       Impact factor: 2.472

2.  IMA Genome - F16 : Draft genome assemblies of Fusarium marasasianum, Huntiella abstrusa, two Immersiporthe knoxdaviesiana isolates, Macrophomina pseudophaseolina, Macrophomina phaseolina, Naganishia randhawae, and Pseudocercospora cruenta.

Authors:  Brenda D Wingfield; Lieschen De Vos; Andi M Wilson; Tuan A Duong; Niloofar Vaghefi; Angela Botes; Ravindra Nath Kharwar; Ramesh Chand; Barsha Poudel; Habibu Aliyu; Martin J Barbetti; ShuaiFei Chen; Pieter de Maayer; FeiFei Liu; Sudhir Navathe; Shagun Sinha; Emma T Steenkamp; Hiroyuki Suzuki; Kalonji A Tshisekedi; Magriet A van der Nest; Michael J Wingfield
Journal:  IMA Fungus       Date:  2022-02-23       Impact factor: 3.515

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.